In 2026, the 1st Circuit upheld dismissal of class actions challenging weight-loss drug exclusions under Section 1557 (e.g., Holland v
Another study involving over 4 million people found that those taking semaglutide and liraglutide had a slightly higher relative risk of pancreatitis compared to those using bupropion-naltrexone (Contrave) or orlistat (Alli and Xenical)
The documented protocol for both vial sizes uses 3 mL of bacteriostatic water
GLP-1 activation delays gastric emptying, increases satiety signals to the brain, and enhances insulin secretion in response to food intake
Common Misconceptions Misconception 1: "Research-grade" implies human safety
Reid, M., Badaloo, A., Forrester, T